{"id":"https://openalex.org/W2056320680","doi":"https://doi.org/10.1159/000047960","title":"Efficacy, Tolerability and Safety of Oral Eletriptan and Ergotamine plus Caffeine (Cafergot\u00ae) in the Acute Treatment of Migraine: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Comparison","display_name":"Efficacy, Tolerability and Safety of Oral Eletriptan and Ergotamine plus Caffeine (Cafergot\u00ae) in the Acute Treatment of Migraine: A Multicentre, Randomised, Double-Blind, Placebo-Controlled Comparison","publication_year":2002,"publication_date":"2002-01-01","ids":{"openalex":"https://openalex.org/W2056320680","doi":"https://doi.org/10.1159/000047960","mag":"2056320680","pmid":"https://pubmed.ncbi.nlm.nih.gov/11844898"},"language":"en","primary_location":{"id":"doi:10.1159/000047960","doi":"https://doi.org/10.1159/000047960","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000047960","pdf_url":null,"source":{"id":"https://openalex.org/S162735375","display_name":"European Neurology","issn_l":"0014-3022","issn":["0014-3022","1421-9913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neurology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107910424","display_name":"Hans\u2010Christoph Diener","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Hans-Christoph Diener","raw_affiliation_strings":["Department of Neurology, University of Essen, Essen, Germany. h.diener@uni-essen.de","Department of Neurology, University of Essen, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University of Essen, Essen, Germany. h.diener@uni-essen.de","institution_ids":["https://openalex.org/I62318514"]},{"raw_affiliation_string":"Department of Neurology, University of Essen, and","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083964295","display_name":"Jan\u2010Peter Jansen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jan-Peter Jansen","raw_affiliation_strings":["Schwerpunktpraxis Schmerztherapie, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schwerpunktpraxis Schmerztherapie, Berlin, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038643684","display_name":"Avinoan Reches","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2799899409","display_name":"Hadassah Medical Center","ror":"https://ror.org/01cqmqj90","country_code":"IL","type":"healthcare","lineage":["https://openalex.org/I2799899409"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Avinoan Reches","raw_affiliation_strings":["Department of Neurology, Hadassah University Hospital, Jerusalem, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Hadassah University Hospital, Jerusalem, Israel","institution_ids":["https://openalex.org/I2799899409"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040917727","display_name":"Julio Pascual","orcid":"https://orcid.org/0000-0002-3189-7573","observed_orcids":["https://orcid.org/0000-0002-3189-7573"]},"institutions":[{"id":"https://openalex.org/I4210099858","display_name":"Marqu\u00e9s de Valdecilla University Hospital","ror":"https://ror.org/01w4yqf75","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210099858"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Julio Pascual","raw_affiliation_strings":["Service of Neurology, University Hospital Marqu\u00e9s de Valdecilla, Santander, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Service of Neurology, University Hospital Marqu\u00e9s de Valdecilla, Santander, Spain","institution_ids":["https://openalex.org/I4210099858"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048988574","display_name":"Daniela Pitei","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniela Pitei","raw_affiliation_strings":["Pfizer Central Research, Sandwich, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Central Research, Sandwich, and","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5025629771","display_name":"Timothy J. Steiner","orcid":"https://orcid.org/0000-0002-1882-4337","observed_orcids":["https://orcid.org/0000-0002-1882-4337"]},"institutions":[{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Timothy J. Steiner","raw_affiliation_strings":["Division of Neuroscience, Imperial College School of Medicine, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Neuroscience, Imperial College School of Medicine, London, UK","institution_ids":["https://openalex.org/I47508984"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":7.1957,"has_fulltext":false,"cited_by_count":124,"citation_normalized_percentile":{"value":0.97444844,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"47","issue":"2","first_page":"99","last_page":"107"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10498","display_name":"Migraine and Headache Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10420","display_name":"Intracranial Aneurysms: Treatment and Complications","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eletriptan","display_name":"eletriptan","score":0.9940000176429749},{"id":"https://openalex.org/keywords/ergotamine","display_name":"ergotamine","score":0.7720000147819519},{"id":"https://openalex.org/keywords/caffeine","display_name":"caffeine","score":0.9769999980926514},{"id":"https://openalex.org/keywords/migraine","display_name":"migraine","score":0.7720000147819519},{"id":"https://openalex.org/keywords/acute-migraine-treatment","display_name":"acute migraine treatment","score":0.9259999990463257},{"id":"https://openalex.org/keywords/5-ht1-receptor-agonists","display_name":"5-HT1 receptor agonists","score":0.8379999995231628},{"id":"https://openalex.org/keywords/nausea","display_name":"nausea","score":0.5220000147819519},{"id":"https://openalex.org/keywords/photophobia","display_name":"photophobia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/phonophobia","display_name":"phonophobia","score":0.9829999804496765},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.8610000014305115},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.6439999938011169},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.7210000157356262},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.5789999961853027},{"id":"https://openalex.org/keywords/migraine-with-aura","display_name":"migraine with aura","score":0.5590000152587891},{"id":"https://openalex.org/keywords/migraine-without-aura","display_name":"migraine without aura","score":0.8999999761581421},{"id":"https://openalex.org/keywords/placebo-controlled-comparison","display_name":"placebo comparison","score":0.3919999897480011},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.46000000834465027},{"id":"https://openalex.org/keywords/headache-related-disability","display_name":"headache-related disability","score":0.3630000054836273},{"id":"https://openalex.org/keywords/migraine-disability","display_name":"migraine disability","score":0.3619999885559082}],"concepts":[{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8494929075241089},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7699964642524719},{"id":"https://openalex.org/C2778541695","wikidata":"https://www.wikidata.org/wiki/Q133823","display_name":"Migraine","level":2,"score":0.7358934283256531},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7260940074920654},{"id":"https://openalex.org/C2778871607","wikidata":"https://www.wikidata.org/wiki/Q416978","display_name":"Sumatriptan","level":4,"score":0.6081557273864746},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.6005517244338989},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.5451379418373108},{"id":"https://openalex.org/C2779929513","wikidata":"https://www.wikidata.org/wiki/Q419186","display_name":"Ergotamine","level":3,"score":0.4375763535499573},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4241180121898651},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3740687370300293},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.16676509380340576},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002110","descriptor_name":"Caffeine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002110","descriptor_name":"Caffeine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004338","descriptor_name":"Drug Combinations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004878","descriptor_name":"Ergotamine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004878","descriptor_name":"Ergotamine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008881","descriptor_name":"Migraine Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014363","descriptor_name":"Tryptamines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017366","descriptor_name":"Serotonin Receptor Agonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1159/000047960","doi":"https://doi.org/10.1159/000047960","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000047960","pdf_url":null,"source":{"id":"https://openalex.org/S162735375","display_name":"European Neurology","issn_l":"0014-3022","issn":["0014-3022","1421-9913"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Neurology","raw_type":"journal-article"},{"id":"pmid:11844898","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11844898","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European neurology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W48338217","https://openalex.org/W1989109809","https://openalex.org/W2019765414","https://openalex.org/W2034286444","https://openalex.org/W2036354453","https://openalex.org/W2050603173","https://openalex.org/W2066723773","https://openalex.org/W2090820748","https://openalex.org/W2113724670","https://openalex.org/W2146829593","https://openalex.org/W2147688165","https://openalex.org/W2153114243","https://openalex.org/W2167990168","https://openalex.org/W2418244508","https://openalex.org/W2521121750","https://openalex.org/W4248790175"],"related_works":["https://openalex.org/W2521121750","https://openalex.org/W2005537302","https://openalex.org/W48338217","https://openalex.org/W7028022356","https://openalex.org/W2054233983","https://openalex.org/W2013751385","https://openalex.org/W2141137381","https://openalex.org/W2050659421","https://openalex.org/W1999697951","https://openalex.org/W2119249022"],"abstract_inverted_index":{"The":[0,54],"5-HT(1B/1D/1F)":[1],"agonist":[2],"eletriptan,":[3],"at":[4,87,152,179,247],"an":[5],"oral":[6,37,264,276],"dose":[7],"of":[8,27,59,64,69,203,273],"80":[9],"mg,":[10,129,132,163,166,186,189,219,224,230,235],"has":[11],"been":[12],"shown":[13],"to":[14,147],"be":[15],"more":[16,125,156,207,267],"efficacious":[17,268],"than":[18,134,209,275],"sumatriptan":[19],"100":[20,49],"mg":[21,45,50],"and":[22,57,61,66,91,95,239,257,278],"placebo":[23],"in":[24,73,211,269],"the":[25,270],"treatment":[26,38,272],"migraine":[28,40,82,274],"attacks":[29,41],"with":[30,48],"or":[31,149,244,255],"without":[32],"aura.":[33],"Another":[34],"commonly":[35],"prescribed":[36],"for":[39,198],"is":[42,266,279],"Cafergot":[43,70,210,277],"(1":[44],"ergotamine":[46],"tartrate":[47],"caffeine":[51],"per":[52],"tablet).":[53],"efficacy,":[55],"tolerability":[56],"safety":[58],"40-":[60],"80-mg":[62],"doses":[63,202],"eletriptan":[65,157,204,265],"2":[67,112,153,248],"tablets":[68],"were":[71,182,205,252],"compared":[72],"a":[74,105],"double-blind,":[75],"randomised,":[76],"placebo-controlled,":[77],"parallel-group":[78],"trial":[79,261],"involving":[80],"733":[81],"patients.":[83],"Patients":[84],"recorded":[85],"symptoms":[86],"baseline":[88],"(before":[89],"treatment)":[90],"1,":[92],"2,":[93],"4":[94],"24":[96],"h":[97,181],"after":[98],"dosing.":[99],"Headache":[100],"intensity":[101],"was":[102],"assessed":[103],"on":[104],"4-point":[106],"scale":[107],"(3":[108],"=":[109,113,117,121,245],"severe":[110],"pain,":[111,115,119],"moderate":[114,256],"1":[116,180],"mild":[118,148,254],"0":[120],"no":[122,150,160],"pain).":[123],"Significantly":[124],"eletriptan-treated":[126],"patients":[127,136],"(80":[128,162,185,218,229],"68%;":[130],"40":[131,165,188,223,234],"54%)":[133],"Cafergot-treated":[135],"(33%;":[137],"p":[138,172,195,220,225,231,236],"<":[139,173,196,215,221,226,232,237,243],"0.001)":[140,246],"reported":[141,159],"headache":[142,176],"response":[143,177],"(improvement":[144],"from":[145],"moderate-to-severe":[146],"pain)":[151],"h.":[154,249],"Substantially":[155],"recipients":[158],"pain":[161],"38%;":[164],"28%;":[167],"Cafergot,":[168,191],"10%;":[169],"placebo,":[170,193],"5%;":[171],"0.001).":[174],"Eletriptan":[175],"rates":[178],"significantly":[183,206],"higher":[184],"39%;":[187],"29%;":[190],"13%;":[192,194],"0.002":[197],"each":[199],"comparison).":[200],"Both":[201],"effective":[208],"reducing":[212],"nausea":[213],"(p":[214,242],"0.0001),":[216],"photophobia":[217],"0.0001;":[222,233],"0.002),":[227],"phonophobia":[228],"0.003)":[238],"functional":[240],"impairment":[241],"Adverse":[250],"events":[251],"generally":[253],"transient.":[258],"This":[259],"randomised":[260],"shows":[262],"that":[263],"acute":[271],"well":[280],"tolerated.":[281]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":8},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}